Latest debt-to-equity ratio
Unicycive Therapeutics Debt-to-equity ratio
Direct answer
Unicycive Therapeutics's debt-to-equity ratio is 1.26%.
The verified market snapshot reports 1.26%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 25, 2026.
Get free Unicycive Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 1.26%
Explore related company data
View Unicycive Therapeutics's market capitalizationView Unicycive Therapeutics's price-to-book ratioView Unicycive Therapeutics's return on equityView Unicycive Therapeutics's dividend yieldView Unicycive Therapeutics's 52-week price rangeView Unicycive Therapeutics's profit marginView all Unicycive Therapeutics key metricsReturn to Unicycive Therapeutics profile